402 related articles for article (PubMed ID: 26807761)
41. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.
Nummela P; Lammi J; Soikkeli J; Saksela O; Laakkonen P; Hölttä E
Am J Pathol; 2012 Apr; 180(4):1663-74. PubMed ID: 22326753
[TBL] [Abstract][Full Text] [Related]
42. Implications of Hypoxia in Breast Cancer Metastasis to Bone.
Gilkes DM
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706047
[TBL] [Abstract][Full Text] [Related]
43. Extracellular matrix components in breast cancer progression and metastasis.
Oskarsson T
Breast; 2013 Aug; 22 Suppl 2():S66-72. PubMed ID: 24074795
[TBL] [Abstract][Full Text] [Related]
44. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
Sterling JA; Edwards JR; Martin TJ; Mundy GR
Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
[TBL] [Abstract][Full Text] [Related]
45. Extracellular matrix proteins in metastases to the liver - Composition, function and potential applications.
Nyström H
Semin Cancer Biol; 2021 Jun; 71():134-142. PubMed ID: 32526353
[TBL] [Abstract][Full Text] [Related]
46. Hypoxia and Redox Signaling on Extracellular Matrix Remodeling: From Mechanisms to Pathological Implications.
Labrousse-Arias D; Martínez-Ruiz A; Calzada MJ
Antioxid Redox Signal; 2017 Oct; 27(12):802-822. PubMed ID: 28715969
[TBL] [Abstract][Full Text] [Related]
47. Special issue: Extracellular matrix: Therapeutic tools and targets in cancer treatment.
Schaefer L; Reinhardt DP
Adv Drug Deliv Rev; 2016 Feb; 97():1-3. PubMed ID: 26872878
[TBL] [Abstract][Full Text] [Related]
48. Extracellular Matrix Biomarkers in Colorectal Cancer.
Kim MS; Ha SE; Wu M; Zogg H; Ronkon CF; Lee MY; Ro S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502094
[TBL] [Abstract][Full Text] [Related]
49. Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study.
Kharaishvili G; Cizkova M; Bouchalova K; Mgebrishvili G; Kolar Z; Bouchal J
J Clin Pathol; 2011 Nov; 64(11):977-82. PubMed ID: 21742751
[TBL] [Abstract][Full Text] [Related]
50. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
Yoneda T; Hiraga T
Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
[TBL] [Abstract][Full Text] [Related]
51. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
52. Animal model for mammary tumor growth in the bone microenvironment.
Futakuchi M; Singh RK
Breast Cancer; 2013 Jul; 20(3):195-203. PubMed ID: 23335063
[TBL] [Abstract][Full Text] [Related]
53. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.
Cher ML; Biliran HR; Bhagat S; Meng Y; Che M; Lockett J; Abrams J; Fridman R; Zachareas M; Sheng S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7847-52. PubMed ID: 12788977
[TBL] [Abstract][Full Text] [Related]
54. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors.
Matteucci E; Maroni P; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
Eur J Cancer; 2013 Jan; 49(1):231-44. PubMed ID: 22717556
[TBL] [Abstract][Full Text] [Related]
55. Dynamic modeling of bone metastasis, microenvironment and therapy: Integrating parathyroid hormone (PTH) effect, anti-resorptive and anti-cancer therapy.
Coelho RM; Lemos JM; Alho I; Valério D; Ferreira AR; Costa L; Vinga S
J Theor Biol; 2016 Feb; 391():1-12. PubMed ID: 26657065
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of invasion and metastasis in human neuroblastoma.
Ara T; DeClerck YA
Cancer Metastasis Rev; 2006 Dec; 25(4):645-57. PubMed ID: 17160711
[TBL] [Abstract][Full Text] [Related]
57. Matricellular proteins: a sticky affair with cancers.
Chong HC; Tan CK; Huang RL; Tan NS
J Oncol; 2012; 2012():351089. PubMed ID: 22481923
[TBL] [Abstract][Full Text] [Related]
58. Dermatopontin: a potential predictor for metastasis of human oral cancer.
Yamatoji M; Kasamatsu A; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Int J Cancer; 2012 Jun; 130(12):2903-11. PubMed ID: 21796630
[TBL] [Abstract][Full Text] [Related]
59. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
60. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
